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THE EFFECT OF DBS SETTINGS ON NEUROPSYCHOLOGICAL FUNCTIONING 
IN PATIENTS WITH PARKINSON’S DISEASE 
KATHLEEN M. MASH 
ABSTRACT 
 
Parkinson’s disease (PD) is an idiopathic progressive neurological disorder. 
Improvement in Parkinsonian motor function has been established with subthalamic 
nucleus (STN) deep brain stimulation (DBS). Recently, the relationship between DBS 
stimulator settings and motor function has begun to be explored; however, no study to 
date has investigated the relationship between DBS settings and neuropsychological 
functioning. This study evaluated the extent to which DBS settings (i.e., amplitude, 
frequency, and pulse width) are associated with post-operative performances on the 
RBANS (Repeatable Battery for the Assessment of Neuropsychological Status). The 
study was a prospective clinical trial of STN DBS for the treatment of medication 
refractory PD.  Twenty patients were identified that met study inclusion and exclusion 
criteria. All participants completed neuropsychological evaluations, including the 
RBANS. Correlations revealed significant relationships between amplitude and pulse 
width with RBANS indices of visuospatial/constructional ability (r =.55) and immediate 
memory (r = .45). Also, significant relationships were found between amplitude and line 
orientation (r =.45) and pulse width and delayed figure recall (r =.46). Multiple 
regression found DBS stimulator settings, along with symptoms of anxiety, to be 
significant predictors of RBANS scores. While DBS appears to be relatively benign from 
a neuropsychological standpoint, some patients experience more pronounced 
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impairments. One variable that may account for previous variability is DBS stimulation 
parameters. 
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CHAPTER I 
INTRODUCTION 
Patients with Parkinson's disease have shown a wide range of neuropsychological 
or cognitive impairments due to damage of critical brain circuitry, neurotransmitter 
systems, and neuronal pathways. In the initial phases of Parkinson’s disease, patients are 
effectively treated with medications. However, with time and disease progression, the 
drugs become less effective and their use becomes associated with increasingly disabling 
adverse effects. When patients reach the point where they have significant disability 
despite the best available medical therapy, alternate strategies must be considered. It is in 
this context that chronic deep brain stimulation (DBS) is becoming an important 
treatment for patients with Parkinson’s disease and other movement disorders. 
Based on the data, DBS is now widely accepted as safe and efficacious for 
patients who have been diagnosed with idiopathic Parkinson's disease; idiopathic 
meaning of no known cause. Currently, the majority of data on the effect of DBS have 
focused on the reduction of involuntary motor dysfunction following surgery. However, 
data are lacking comparing pre to post-operative neuropsychological function in patients 
with Parkinson's disease. Furthermore, deep brain stimulators have an external control by 
which a trained health care provider is able to adjust the frequency, amplitude, and pulse 
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width of electrical waves that stimulate certain areas of the brain. By adjusting these 
parameters, patients may experience differing clinical responses that may improve or 
hinder their motor and cognitive behavior.  
I will discuss idiopathic Parkinson’s disease and the underlying 
neuropsychological impairments observed in attention, language, visuospatial ability, 
memory, and executive function. Second, the mechanisms of subthalamic nucleus (STN) 
deep brain stimulation will be explained in terms of treatment options for Parkinson’s 
patients no longer responding to medication. Finally, the associations between post-
surgical cognitive performance and stimulator setting are discussed. In addition, a 
comprehensive review of the research literature on each of these issues is presented to 
assess the links between stimulator setting and cognitive function.  
The current literature has limited accounts of the relationship between stimulation 
parameters and cognition, behavior, or subjective psychotropic effects. No studies have 
systematically varied stimulation parameters and assessed cognition in a within-subject 
design. This study attempted to determine how fluctuations in amplitude, frequency, and 
pulse width affect neuropsychological function in patients with idiopathic Parkinson’s 
disease. Neuropsychological measures include the Repeatable Battery for the Assessment 
of Neuropsychological Status (RBANS) which is a standardized psychological test used 
to evaluate neuropsychological function. It is hypothesized that variations in amplitude, 
frequency, and pulse width may cause changes in neuropsychological function post-
surgery.  
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CHAPTER II 
 
 
REVIEW OF THE RELEVANT LITERATURE 
 
 
Parkinson’s disease  
  
 Parkinson’s disease (PD), or primary parkinsonism, is an idiopathic progressive 
neurological disorder that is manifested clinically by bradykinesia (or slowness in the 
initiation of voluntary movement), resting tremor, rigidity, and postural reflex 
impairment (Adams, Parsons, Culbertson, & Nixon, 1996). All individuals with PD show 
a moderately severe, high focal nerve-cell loss in the pars compacta of the substantia 
nigra (Gibb, 1992). The dopamine depletion that occurs as a result of the nerve-cell 
degeneration in PD reduces the concentration of this neurotransmitter along the nigro-
striatal pathway, resulting in an imbalance in the activity of motor systems (Adams et al., 
1996). Beyond these motor impairments, cognitive dysfunctions often occur over the 
course of PD. Functional disturbances of fronto-striatal loops resulting from deficient 
dopamine transmission due to cell loss within the substantia nigra is considered the 
primary neural correlate for cognitive deficits in PD (Brand et al., 2004).  
Until relatively recently, the sole focus of research in Parkinson’s disease was the 
motor symptoms associated with this neurodegenerative disorder. In the last few decades, 
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it has become increasingly apparent that PD involves a variety of cognitive impairments 
(Whittington, Podd, & Stewart-Williams, 2006). Numerous studies have reported 
cognitive dysfunctions in patients with Parkinson’s disease relative to healthy volunteers 
on measures of declarative memory, working memory, visuospatial skills, language, 
frontal lobe capacities, and attentional processes (Locascio, Corkin, & Growdon, 2003). 
It is important to note that although there is some consensus that PD involves cognitive 
impairments, the nature of these impairments is controversial. It appears that several 
variables, such as severity of disease and age of onset, may be related to the observed 
deficits in neuropsychological functioning. Due to the age of onset of PD, it is also 
somewhat inconclusive and at times difficult to determine what constitutes a decline in 
cognitive functioning. That is, the decline may be secondary to a neurodegenerative 
disorder or be a consequence of the normal aging process.   
Nevertheless, the most salient feature that emerges from these studies is the 
extensive individual variation in the patterning of the motoric and cognitive 
symptomology of the disease (Adams et al., 1996). Burton, Strauss, Hultsch, Moll, and 
Hunter (2006) observed intraindividual variability, or inconsistency, as a marker in 
neurological dysfunction in patients with Parkinson’s disease. Intraindividual variability 
refers to relatively short-term, reversible changes in a person’s performance within a task 
administered on a single occasion or the same task administered across multiple 
occasions over short intervals of time. Research to date indicates that intraindividual 
variability can be reliably measured, is substantial in magnitude, and tends to be a 
relatively stable characteristic of the individual (Burton et al., 2006). In this study 
participants were assessed on four separate occasions on two basic reaction time tasks 
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and two recognition memory tasks. Results showed that participants with Parkinson’s 
disease were more variable across trials than were healthy controls on all measures of 
cognitive functioning. The findings suggest that there may be some specificity of the 
neurological mechanisms underlying intraindividual variability, such as differences in the 
neural structures or neural pathways affected, or the diffuseness of the damage (Burton et 
al., 2006). Therefore, due to the high degree of intraindividual variability amongst 
Parkinson’s patients, it is important to question the reliability and validity of empirical 
findings concerning the observed neuropsychological dysfunction in Parkinson’s disease.  
Attention 
The neuropsychology of Parkinson’s disease refers to the cognitive and 
behavioral changes which accompany the disorder (Taylor & Saint-Cyr, 1995). Even 
non-demented, non-depressed PD patients are said to suffer a variable mix of specific 
cognitive weaknesses, which, according to the functions studied, implicate memory, 
language, visuospatial processes, abilities of an executive nature, and attention. 
 Neuropsychological research has suggested that there are many different forms 
and processes of attention. Studies have suggested that patients with frontal lobe damage 
have demonstrated deficits in tasks that require sustained, divided, and selective attention 
(Lee, Wild, Hollnagel, & Grafman, 1999). Lee et al. (1999) state that one approach to 
understanding the role of the frontal lobes in attention has viewed attention as the process 
of allocating resources. One specific aspect of attention allocation, termed selective 
attention, involves the ability to focus upon one target, while ignoring other interfering 
stimuli. Studies have supported the contention that patients with Parkinson’s disease 
suffer from a disorder of attention on task-switching experiments as evidenced by 
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increased susceptibility to interference from distracter items as compared with controls 
(Lee et al., 1999). 
Lee et al. (1999) examined selective attention in Parkinson patients by using the 
flanker task devised by Eriksen (1995). The flanker task has been employed to investigate 
selective attention in various patient populations. This task consists of presenting a cross 
on a computer monitor which indicates where a target letter will appear. Then, a letter 
(either S or H) appears directly above the fixation. The participant must then type the 
letter as quickly as possible and ignore any other letters that are presented at various 
distances on the monitor. The target letter was presented either without distracters 
(control condition) or was flanked by letters at various distances. The flanking letters 
could either have the same identity as the target letter (distracter compatible condition), 
have been a target on the previous trial (distracter incompatible condition), or were letters 
other than the target letters (distracter neutral condition). 
Results show that patients produced results consistent with the effects originally 
described by Eriksen (cited in Lee et al., 1999). The patients, when compared to controls, 
were slower in their response times across the spatial distances and the different 
interference conditions. Also, as the spatial distance between the flanking letters and 
target letter increased, the target response times decreased across the conditions. Finally, 
the different conditions influenced the target response times in all of the groups, with the 
distracter incompatible condition producing the slowest reaction time and the compatible 
condition producing the fastest reaction time (Lee et al., 1999). However, the results 
using this task suggest that the cognitive processes underlying selective attention are 
spared in patients with PD. 
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 In comparison with the study by Lee et al. (1999) Corbetta, Miezen, Dobmeyer, 
Shulman, and Petersen (1991) found that their selective attention task activated basil 
ganglia, the lateral orbitofrontal cortex, and the premotor cortex, which are commonly 
affected areas in the brains of Parkinson’s patients. Furthermore, Vendrell, Punjol, 
Jurado, Molet, and Grafman (1995) found that PD patients with frontal lobe deficits 
tended to perform worse than controls on the Stroop task. However, the flanker task 
differs from the Stroop test in that in the flanker task, the distraction surrounds the target 
whereas in the Stroop test, the distraction spatially overlaps with the target stimulus 
shown to the subject. Therefore, task differences might account for differences in frontal 
lobe lesion effects upon seemingly similar attentional processes (Vendrell et al., 1995). 
 In another study examining subcortical attentional dysfunction by Roman et al. 
(1998), participants were presented with global-local figures and were instructed to focus 
their attention on either the global or local level. Stimuli were either consistent with the 
same form at the global and local levels, (a large one made up of smaller ones), or 
inconsistent with different forms at the global and local levels (a large one made up of 
smaller twos). Findings indicated that subjects responded more slowly to inconsistent 
than consistent stimuli; however, the results were not significant.  
 This study’s finding that patients with PD have intact focused attention on a 
global-local task differs from past research (Roman et al., 1998). Several past studies 
have demonstrated an increased susceptibility to distraction by unattended features of 
stimuli in patients with PD. In addition, Maddox, Filoteo, Delis, and Salmon (1996) 
found that patients with PD were impaired on a perceptual decision task requiring them to 
attend to and classify one feature of a stimulus while ignoring another. The differences in 
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the findings may be explained in terms of task complexity. Task duration may also 
influence focused attention in that longer tasks may produce deficient performances in 
sustained attention in PD patients as compared to shorter tasks. Overall, these results 
provide further evidence for the heterogeneity of attentional dysfunction among 
subcortical degenerative illnesses (Roman et al., 1998). 
Language 
 While the motor and cognitive deficits in PD have been well documented, deficits 
in language and language processing are also a frequently reported feature (Angwin, 
Chenery, Copland, Murdoch, & Silburn, 2007). The most research on PD patients has 
been conducted in the area of verbal fluency. Verbal fluency measures have revealed a 
selective deficit associated with category naming. Specifically, PD patients without 
dementia show significant impairment in category naming for a semantic target, such as 
fruit, but perform normally on tests of letter fluency (Auriacombe et al., 1993). Although 
several explanations have been proposed to account for this selective fluency deficit, 
preliminary reports by Auriacombe et al. (1993) have suggested that impaired category 
naming is related to the lexical retrieval impairment that has been observed in PD.  
 Azuma, Cruz, Bayles, Tomoeda, and Montgomery (2003) conducted a 
longitudinal study of neuropsychological change in individuals with PD, and reported 
that of the ten neuropsychological tests given, only semantic, or letter fluency, 
performance significantly declined by second testing two years later. Testa et al. (1998) 
also observed the semantic fluency performance of patients with cortical and subcortical 
neurodegenerative diseases. In parallel with previous data, they state that in PD, there is a 
marked and progressive reduction in total word output on verbal fluency tests. However, 
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these changes are usually attributed to retrieval failures rather than to degradation of the 
semantic memory stores. Studies of the patterns of responding of normal participants on 
semantic fluency tasks reveal that semantically related words tend to cluster together, 
occurring in spurts over time (Gruenewald & Lockhead, 1980). PDD patients 
(Parkinson’s disease with dementia) exhibited reduced cluster sizes as compared to PD 
patients. Overall, these findings indicate that semantic cluster size reflects efficiency of 
access to semantic knowledge, which is similarly compromised in subcortical and cortical 
diseases (Testa et al., 1998). 
 Ho, Iansek, and Bradshaw (2002) tested both the role of attention and 
Parkinsonian speech control by using a dual-task paradigm. While it is well-known that 
skeletal motor performance is impaired when Parkinson’s disease patients are required to 
perform two motor acts simultaneously, this has not been examined in the context of 
speech motor control (Ho et al., 2002). This experiment was comprised of a joystick 
which was placed over a visual display scale. The participant had to track a needle across 
the visual display scale. Moving the joystick in the opposite direction could counteract 
random movement of a needle. As a result, participants attempted to control the position 
of the needle so that it was in the middle section of the plate at all times. In addition, two 
different procedures were utilized in order to concurrently assess Parkinsonian speech: a 
numerical sequences condition in which the participants had to count forward and 
backward as long as possible without taking a breath while tracking the needle; or a 
conversation condition in which the participants had to ask and answer questions about a 
familiar setting, such as their house or garden, in as much detail as possible.  
 Results showed that instead of talking and performing the concurrent task in 
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parallel, patients alternately shifted attention from one task to the other, in a sequential 
manner. When the needle drifted from the target position, they would conveniently, and 
sometimes inappropriately, pause (Ho et al., 2002). Results suggest that PD patients show 
an additional deterioration of temporal deficits in speech when attentional resources are 
reduced by a distracter task. It therefore appears that this deterioration transcends motor 
systems, and is critically driven by the higher-order frontostriatal impairment in PD (Ho 
et al., 2002). 
In addition to language or speaking deficits, language processing is also 
compromised in PD patients. For instance, researchers have reliably demonstrated that 
some patients with PD have poorer comprehension of sentences containing complex 
clauses with a noncanonical structure, such as “the girl that the boy hit dropped the 
parcel,” compared to sentences with simpler canonical structures, such as “the girl that hit 
the boy dropped the parcel” (Grossman et al., 2000). Angwin et al. (2007) studied the 
speed of lexical activation in Parkinson’s disease. Stimuli were presented as a continuous 
list of words and nonwords, with semantic priming effects being measured across 
intervals. The results revealed longer delays in lexical activation for PD patients with 
poor comprehension of noncanonical sentences, suggesting that the 
speed of lexical access may be compromised in PD, and this feature may contribute to 
certain sentence comprehension difficulties (Angwin et al., 2007). 
Overall, reports of linguistic functions among PD patients indicate a relative 
preservation of verbal abilities. However, a proportion of PD patients suffer from speech 
problems, characterized by monotony of pitch and loudness, reduced stress, short 
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phrases, and segmented rushes of speech. These speech impairments, coupled with 
reduced gestural movements, compromise communication skills (Adams et al., 1996). 
Visuospatial/Construction 
 Visuospatial dysfunction, as one of the most frequently reported cognitive deficits 
in PD, reveals an interesting gradient of functional decline (Adams et al., 1996). A series 
of studies by Levin and colleagues (Levin et al., 1991) suggested that facial recognition is 
one of the initial visuospatial skills to show decline in patients both with and without 
dementia. However, PD patients without dementia retain the ability to formulate angular 
judgments and are able to identify geometric figures. Tasks involving mental object 
assembly, such as the Hooper Visual Organization Test, show a decline as a function of 
disease duration and are independent of dementia (Adams et al., 1996). 
 In an effort to validate the observed deficits in visuo-constructional ability in PD 
patients, Giraduo, Gayraud, and Habib (1997) studied the visuospatial ability of PD 
patients and elderly adults in location memory tasks. In the more effortful task, 11 PD 
patients, 10 elderly control subjects, and 13 young control subjects were given 3 minutes 
to learn the layout of 12 places labeled on a map and then reproduce it. In the less 
effortful task, 9 new PD patients, 9 new elderly control subjects, and 10 new young 
control subjects were given 3 minutes to learn the layout of 12 black dots and then asked 
to reproduce it. In both cases the task was repeated twice. Results for the first task 
confirmed the effortful nature of the task as well as observed lower performance for PD 
patients with a high degree of variability. As with remembering dot locations, the PD 
patients also performed significantly worse, thus proving their difficulty with organizing 
and planning information. These results suggest deficits in the executive functions.  
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 Pillon et al. (1997) also observed the connection between memory and spatial 
location in PD patients. They showed that typical, non-PDD patients have a severe 
memory deficit for visuospatial location of pictures, contrasting with the relative 
preservation of verbal memory and mild difficulties in visuospatial and executive 
functions. Since the patients in their study were not demented, it was proposed that their 
memory deficit might result from dopaminergic depletion. In the current study, the 
performance of 10 PD patients was compared with 14 controls on a visuospatial learning 
test. The task required little motor or constructive functions and was designed to allow 
control of encoding and comparison of free recall, cued recall, and recognition. 
Compared to controls, PD patients showed a lower performance in memory for 
visuospatial location of pictures, contrasting with relative preservation of verbal memory, 
perceptive visuospatial and executive functions (Pillon et al., 1997). These results 
confirm the deficits of visuospatial memory, even at an early stage of Parkinson’s 
disease.   
 In another attempt to link executive function and visuospatial ability, Cronin-
Golomb and Braun (1997) raised the question as to whether a visuospatial deficit may 
account for poor performance on a task of executive function, specifically on Raven’s 
Coloured Progressive Matrices (RCPM). Fifty non-demented participants with PD and 39 
age-matched healthy control participants were used in the study. The authors 
hypothesized that the PD group should perform deficiently not only on the B subtest of 
the RCPM, but also on the easy A subtest, which mainly assesses visual closure rather 
than logical reasoning capacities (Cronin-Golomb & Braun, 1997). Furthermore, it was 
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hypothesized that PD performance on the visual A (visuospatial) subtest of the RCPM 
would be predicted by performance on other visuospatial tests.  
 Results showed that the authors’ first hypothesis was supported. The impairment 
included a small but significant group difference on subtest A, which assesses 
visuospatial ability. The second hypothesis was also supported in that RCPM-A 
performance was predicted at a significant level by the visuospatial composite score but 
not by the executive function or verbal memory composite scores. Overall, the PD group 
made significantly more errors than the control group on all RCPM subtests, including 
the subtest that mainly assessed visuospatial function. These results support arguments 
for the existence of genuine, if selective, deficits in visuospatial cognition in PD. The 
results also suggest that impaired PD performance on the RCPM may be due in part to 
deficient visuospatial function and its effect on performance subtest A (Cronin-Golomb 
& Braun, 1997).  
 It has been shown that PD patients show deficits in facial recognition due to 
declines in visuospatial ability. Dujardin et al. (2004) studied deficits in decoding 
emotional facial expressions in PD. Eighteen PD patients participated in the study 
together with 18 matched control subjects. The participants’ task was to rate the emotion 
portrayed by each face and to quantify its intensity. In order to achieve this, they had to 
rate each expression on seven point scales for each of seven basic emotions: happiness 
 sadness, fear, anger, disgust, surprise, and shame. These scales were presented on a 
computer screen below each facial expression (Dujardin et al., 2004). Subjects also 
participated in an executive function task. Results showed that early in the course of the 
disease, untreated PD patients were significantly impaired in decoding emotional facial 
 13 
 
expressions (EFEs), as well as in executive function. Overall, non-verbal emotional 
processing is disturbed in PD. These findings suggest that deficits in executive function, 
memory, and visuospatial ability in PD patients may contribute to their lack of facial 
recognition.  
Memory 
 The prevalence and nature of memory impairments in non-demented patients with 
idiopathic Parkinson’s disease has been the subject of considerable research effort (Ivory, 
Knight, Longmore, & Caradoc-Davies, 1999). However, empirical research shows that 
memory yields contradictory findings when exploring neuropsychological dysfunction in 
PD patients. Explanations for the perceived differences include differences in task 
complexity, differences in types of task, age of onset, and degree of impairment due to 
illness. Additionally, different types of memory appear to be compromised in PD which 
include both implicit and explicit memory, as well as several impairments with both 
recall and recognition tasks.  
 There is evidence for deficits in recall memory among non-demented PD patients. 
These deficits affect both verbal and nonverbal recall, and appear to be independent of 
anti-parkinsonian medication (Brown & Marsden, 1990). Studies have been consistent in 
observing memory recall dysfunction in PD patients. Demakis, Sawyer, Fritz, and Sweet 
(2001) studied incidental recall on the WAIS-R digit symbol task. For this task, the 
examinee is asked to recall, without warning, the symbols associated with each number 
immediately after completion of the standard subtest. The test is administered in standard 
fashion except that participants were not stopped after 90 seconds had expired, but 
completed the entire stimulus sheet. Results indicated that PD patients performed below 
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age-related expectations on the standard administration of the digit symbol subtest. Also, 
Demakis et al. (2001) found this simple incidental recall adaptation to be sensitive to 
memory impairment and to be related more strongly to established memory measures 
than were cognitive efficiency measures.  
 Stefanova, Kostic, Ziropadja, Ocic, and Markovic (2001) also observed memory 
recall in patients with early PD by examining the serial positioning effects of word list 
learning across five successive trials. Cued, both verbal and visual paired associate 
learning from the Wechsler Memory Scale-Revised, and uncued, free recall memory 
tasks, such as the RAVLT and ROCFT, were used. Results indicated that impairments 
were found on the uncued memory tasks, in which the PD group performed significantly 
worse than their matched controls. Stefanova et al. (2001) assume that the memory 
problems of the PD group are secondary to frontal system dysfunction. However, they 
state that the serial positioning analyses of the word list, and their dynamic changes over 
five trials in the PD group, could not be entirely explained in terms of frontal 
dysfunction. Therefore, deficits in specific types of memory, such as free recall, may be 
attributable to other underlying cognitive processes.   
 In another attempt to confirm recall deficits in PD patients, Ivory et al. (1999) 
assessed the verbal memory functions of 20 patients with idiopathic PD. Performance 
was compared on tests of immediate recall, word list learning, word completion priming, 
and remote memory. Taken together, results showed the memory impairments present in 
this group of non-demented patients with PD were rather mild. The only specific deficit 
to emerge was that the PD subjects exhibited impairment on a free recall memory test 
when no specific orienting instructions were provided (Ivory et al., 1999). Therefore, it 
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appears that task conditions such as the presence of orienting instructions and retrieval 
cues may determine whether PD patients will experience difficulties on tests of verbal 
and working memory.  
 It has often been reported that PD impairs free recall, but not recognition (Arroyo-
Anllo, Ingrand, Neau, Aireault, & Gil, 2004). The research concerning recognition 
memory is inconsistent, with various studies reporting some form of impaired recognition 
in non-demented PD participants (Whittington et al., 2006). Older research supports the 
notion that recognition in Parkinson’s disease patients remains relatively intact and is 
largely independent of impairments in free recall tasks. However, recent attempts have 
found significant differences between PD patients and matched controls on recognition 
memory tasks. For example, Stebbins, Gabrrrieli, Masciari, Monti, and Goetz (1999) 
found that PD patients, relative to control participants, had intact immediate but impaired 
delayed recognition memory performance. 
 Furthermore, Higginson, Wheelock, Carroll, and Sigvardt (2003) set out to 
provide evidence that recognition and cued recall are not intact in PD patients. They 
hypothesized that PD patients would perform below expectations on measures of a cued 
recall and recognition as well as free recall task, suggesting that memory deficits in PD 
are not solely due to retrieval problems. PD patients were administered the California 
Verbal Learning Test and their performance was compared to a well-matched normative 
sample. A profile analysis revealed that non-demented PD patients exhibited deficits on 
measures of cued recall and delayed recognition that were similar in magnitude to that of 
free recall (Higginson et al., 2005). This was also the case for cued recall deficits 
exhibited by demented patients; however, in this group, recognition was worse than free 
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recall. In both groups, poor recognition appeared due to an elevated number of false 
positive errors (Higginson et al., 2005). 
 Whittington et al. (2006) further investigated deficits in recognition, recall, and 
prospective memory among PD patients, while also observing how task difficulty and 
disease severity moderate these deficits. The comparisons were made between 41 non-
demented PD participants, divided into early-stage and advanced-stage groups, and 41 
matched controls. PD participants exhibited deficits in recognition, recall, and 
prospective memory. The advanced-stage group produced greater deficits than the early-
stage PD group in all tasks, suggesting that these deficits increase in step with overall 
disease severity (Whittington et al., 2006). In addition, the results of three previous 
studies examining recognition memory in PD with the CVLT are consistent with those 
reported here: poor recall and recognition errors with an elevated number of false 
positives. Thus, it appears that evidence of recognition memory impairment is more 
consistently found with the CVLT than with other measures (Higginson et al., 2005). 
This is likely due to the fact that the task involves conceptual ability as well as verbal 
memory and requires examinees to internally generate a problem solving plan or strategy 
(Higginson et al., 2005). 
In an effort to resolve the recognition debate amongst Parkinson patients, 
Whittington, Podd, and Kan (2000) conducted an analysis of the statistical power of 
studies investigating PD-related recognition memory deficits. They discovered that the 
power of the relevant research has generally been too low to reliably detect small-to 
medium-size effects. For example, in 48 studies investigating memory functioning in PD, 
the mean power to detect small effects was just 20% (Whittington et al., 2000). 
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Underpowered studies increase the likelihood that researchers will conclude that there is 
no population effect when in fact there is one. Wittington et al. (2000) also ran a meta-
analysis of studies investigating recognition deficits in PD. They found that small deficits 
in recognition memory do occur in non-demented PD patients. Thus, the view that PD 
involves relatively intact recognition memory may largely be an artifact of underpowered 
studies. Overall, it is clear that Parkinson patients display a wide range of 
neuropsychological dysfunction in the area of verbal and nonverbal recall and recognition 
memory tasks.  
Executive Function 
 Research over the last two decades has provided an extensive body of evidence 
associating frontal lobe type cognitive deficits with Parkinson’s disease (Berry, Nicolson, 
Foster, Behrmann, & Sagar 1999). Traditionally, dysfunction of the complex loop 
between the caudate nucleus and the prefrontal cortex resulting from dopamine 
deficiency is presumed to underlie the cognitive deficits of PD. However, depletion of 
dopamine in the mesocorticolimbic system, which also projects to the prefrontal cortex, 
has led some investigators to suggest that it is the degeneration of this system that causes 
the observed deficits (Berry et al., 1999). Moreover, there is dysfunction of non-
dopaminergic neurotransmitter pathways innervating the frontal cortex in PD. Therefore, 
dysfunction of any one of the major neurotransmitter systems in subcortical-cortical 
pathways may alter cognitive behaviors that are mediated by the frontal lobes (Berry et 
al., 1999). 
Some of the most prominent cognitive deficits of PD patients that comprise 
disturbances of the executive functions include cognitive flexibility, strategy learning and 
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application, working memory, and different forms of higher order attention and 
susceptibility to interferences. Category formation, abstract reasoning, mental planning, 
set shifting and set maintaining are other dysfunctional areas observed in PD patients, 
which further suggest the role of the frontal lobes (Farina et al., 2000). It has been 
hypothesized that neuropsychological decline in PD is secondary to executive 
dysfunction. Early in the course of the illness, cognitive symptoms are predominantly 
“frontal like” and involve set shifting, planning, problem solving, and organization 
(Higginson et al., 2003).  
Higginson et al. (2003) examined the relationship between executive dysfunction 
and working memory in PD patients. They state that working memory is an aspect of 
executive functioning which involves the active manipulation of information in a 
temporary store, thus including processes that may be necessary for other cognitive tasks 
(Higginson et. al, 2003).  Additionally, they hypothesized that working memory would be 
predictive of recall, due to the correlation between working memory and executive 
function. Thirty-two idiopathic PD patients were tested using the CVLT, the letter-
number sequencing task, digit span, similarities, comprehension, and matrix reasoning 
from the WAIS III, the Stroop test, and the Wisconsin Card Sorting Task. Working 
memory predicted 50% of variability in recall (Higginson et. al, 2003). The results 
corroborate previous literature. For example, Cooper, Sagar, and Sullivan (1993) found 
significant correlations between memory and attention and other aspects of executive 
function, suggesting that deficits in the frontal lobes may cause further cognitive decline 
for patients with PD.  
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Farina et al. (2000) also researched the differential impairment of frontal 
functions and explicit memory in early Parkinson’s disease. Results showed that the 
greatest impairment was seen with the Wisconsin card sorting task (WCST) and the odd-
man-out test. The WCST and the odd-man-out test are widely used tests that assess 
abstract behavior and shifting ability. The group of mild PD patients showed a reduced 
number of correct responses on the WCST and a higher error score on the odd-man-out 
test. This finding confirms the previous reports of impaired set shifting and maintaining 
being the first executive ability to be lost in the early stages of PD (Farina et al., 2000).  
In another attempt to investigate possible associations between decision-making 
and executive functions in PD, Brand et al. (2004) examined 20 non-demented PD 
patients and 20 healthy control subjects with a neuropsychological test battery and the 
Game of Dice Task. The neurological test battery consisted of the Mini Mental State 
Examination (MMSE), the Modified Card Sorting Task (MCST), the Controlled Oral 
Word Association Test (COWAT) of verbal fluency, and a word recall task. The Game of 
Dice Task examines decision-making ability in a gambling situation in which explicit 
rules for gains and losses as well as winning probabilities are explained to the participant. 
Results showed that patients with PD were impaired in decision-making tasks with 
explicit rules for gains and losses (Brand et al., 2004). Also, the frequency of 
disadvantageous choices correlated with both executive functions and feedback 
processing. These results further implicate the dysfunction of the prefrontal-striatal loop 
involved in the executive functions of PD patients.  
In order to distinguish impairment in set-shifting in PD from inability to inhibit 
distraction by stimuli that compete for attention, Richards, Cote, and Stern (1993) 
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compared 18 non-demented patients with PD to 13 normal controls on the odd-man-out 
test (OMO) and the Stroop Color-Word Test. PD patients were significantly impaired on 
the OMO, but results were not significant for the Stroop test. Analysis of error patterns 
during the OMO test indicated that the requirement to repeatedly switch rules, rather than 
the requirement to maintain steady responding between rule switches, was responsible for 
impaired OMO performance (Richards et al., 1993). It was concluded that the OMO test 
is fundamentally a test of set shifting, rather than a test of set maintenance in PD. These 
results suggest that impairment in set-shifting function in PD may arise from pathology 
of the fronto-striatal system independently of changes in cognitive ability. 
Deep Brain Stimulation 
 In the initial phases of Parkinson’s disease, patients are effectively treated with 
medications. With time and disease progression, however, the drugs become less 
effective and their use becomes associated with increasingly disabling adverse effects. 
Among the problems that arise are the appearances of motor fluctuations and of drug-
induced involuntary movements or dyskinesias. When patients reach the point where they 
have significant disability despite the best available medication therapy, alternate 
strategies must to be considered. It is in this context that chronic DBS is becoming an 
important treatment for patients with Parkinson’s disease and other movement disorders 
(Lozano, 2001). 
Deep brain stimulators, often called “pacemakers for the brain,” are implantable 
devices that continuously deliver impulse stimulation to specific targeted nuclei of deep 
brain structure. The deep brain stimulator has four contact electrodes which are 
stereotactically placed into the targeted nucleus of the basil ganglia or thalamus (Gang, 
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Chao, Ling, & Lu, 2005). The electrodes are connected to a pulse generator by a wire that 
is tunneled down to the pulse generator from the brain. The pulse generator typically is 
placed in subcutaneous tissue of the chest, much the same as a cardiac pacemaker. 
Stimulation parameters include electrode selection, stimulation pulse amplitude (mV), 
frequency (Hz), and pulse width (µs). These can be adjusted or altered in order to achieve 
maximum clinical effect and minimize side effects (Gang et al., 2005). 
Evidence gathered from experimental models of Parkinsonism in non-human 
primates has shown that the parkinsonian state is characterized by pathological neural 
activity in several relays in the motor system including the thalamus, the internal segment 
of the globus pallidus (Gpi), and the subthalamic nucleus (Lozano, 2001). The 
suppression of this abnormal activity by lesions or through the use of chronic electrical 
stimulation can produce important benefits in experimental models of parkinsonsim and 
in patients with PD. The three main targets in current usage for the treatment of PD are 
the thalamus for tremor and Gpi or STN for bradykinesia, rigidity, tremor, postural gait 
disturbances, and drug-induced involuntary movements in addition to tremor (Lozano, 
2001). However, only STN DBS is pertinent to this review.  
It is plausible that DBS disrupts not only the motor circuits, but also the circuits 
needed for efficient cognitive processing (Gironell et al., 2003). Therefore, post-operative 
programming or adjusting the deep brain stimulator for amplitude, pulse width, or 
frequency becomes crucial to achieve clinically significant improvements in both motor 
control and cognitive function. While pulse width and frequency are usually kept at a 
constant, amplitude varies depending on clinical response and side effects (Volkmann, 
Moro, & Pahwa, 2006). Although it is well-known how stimulator setting is related to the 
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decreased involuntary motor movements of PD, only a few studies have correlated 
stimulator setting and cognitive functioning. Based on the sparse research that has been 
conducted, it is hypothesized that differential variations in amplitude, frequency, and 
pulse width may lead to significant changes in the neuropsychological functioning of PD 
patients.  
Fundamental knowledge regarding the application of electrical currents to deep 
brain structures is far from complete (Temel et al., 2005). One of the more popular 
hypotheses is that DBS causes a reduction of neuronal activity, meaning that the 
stimulation reduces or inactivates neurons in the vicinity of the electrical stimulation. 
Another assumption is that the electrical stimulation causes disruption of basil ganglia 
circuitry, possibly allowing a re-setting function or re-programming of motor control 
(Saint-Cyr et al., 2000). However, Saint-Cyr et al. (2000) state there are many reasons to 
believe that these hypothesized mechanisms may be too simplistic or may not be 
uniformly applied to all structures treated with DBS. Therefore, future studies directed at 
improving the understanding of the mechanism underlying the effect of deep brain 
stimulation will be important for the continued development and application of DBS 
treatment of neurological disease (Gang et al., 2005). 
DBS and Neuropsychological Function 
Although the motor symptoms of PD are not the focus of this review, it is 
important to note that improvements in Parkinsonian motor function have been well 
established with STN DBS. Several studies have found significant reductions in 
bradykinesia, tremor, rigidity, postural reflex, and freezing of gait. Recently, the 
relationship between DBS settings and motor function has begun to be explored. Results 
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have shown that fluctuations in amplitude are strong predictors of the consequent 
improvements of the motoric functioning in PD patients. However, due to small sample 
sizes and the relatively new interest in the area, all results relating specific stimulator 
settings and motor functioning should be taken as preliminary.  
Conversely, the effects of DBS on these non-motor cognitive and psychiatric 
symptoms are less clear (Voon, Kubu, Krack, Houeto, & Troster, 2006). Most studies 
report that cognitive functions do not change significantly upon stimulation. However, 
some authors have noted a trend towards improved executive functions, attention, and 
working memory, whereas other works report cognitive declines in individual cases 
(Perriol et al., 2006). Given these discordant results, it is now generally acknowledged 
that cognitive decline and psychiatric disorders should be evaluated extensively in 
patients applying for surgery. However, despite rigorous selection, some individuals 
nevertheless develop cognitive decline and behavioral disorders after STN stimulation 
(Perriol et al., 2006). To date, no clear explanation has been found. 
 Looking at short-term (3-6 months post surgery) cognitive effects of STN DBS, 
Morrison et al. (2004) reported on a series of PD patients who had undergone bilateral 
STN electrode placement. By comparing the pre-surgical baseline to the post-surgical 
stimulation-on condition, investigators found a decline in verbal fluency and 
improvements on the Trail Making Test (TMT) parts A and B. In another study, Hariz et 
al. (2000) reported the case of a man who had moderate memory deficits pre-surgically 
and demonstrated cognitive deterioration post-operatively. Finally, in a small sample of 
PD patients who underwent unilateral STN DBS, two of three subjects demonstrated 
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minimal cognitive change whereas the third subject declined in verbal fluency, verbal 
learning and memory, and executive functioning (Morrison et al., 2004). 
 Assessment of cognitive functioning at longer follow-up intervals (9-12 months 
post surgery) has revealed more mixed findings. Some authors report no cognitive 
decline or only isolated reductions in verbal fluency following bilateral STN DBS 
(Morrison et al., 2004). For example, in some studies learning ability recovered 
somewhat, whereas performance on frontal lobe tasks either did not improve or continued 
to decline. It could be argued that the persistent deficits observed at long-term follow-up 
were related to Parkinson’s disease progression, rather than to the DBS per se. However, 
if this were the case, all studies with long-term follow-up data would note a similar 
decline in cognitive performance (Morrison et al., 2004). As indicated before, other 
studies have not observed this pattern, suggesting that disease progression may not be the 
primary reason for the persistent reduction in performance following DBS surgery (Saint-
Cyr et al., 2000).  
Although no clear link exists between DBS and cognitive function, research has 
examined correlations between pre and post-operative neuropsychological function of PD 
patients, only to find contradictory results. Saint-Cyr et al. (2000) examined the possible 
neuropsychological changes in patients with advanced idiopathic Parkinson’s disease 
treated with bilateral deep brain stimulation of the subthalamic nucleus. Eleven patients 
were assessed using a full neuropsychological test battery, which consisted of tasks of 
attention and working memory, executive functioning, language, and verbal and visual 
learning, at 3-6 months and 9-12 months post-operatively. Results showed that various 
aspects of frontal striatal functioning were further compromised with bilateral STN DBS. 
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Cognitive processes involving executive functioning, such as working memory, 
phonemic fluency, encoding efficiency, susceptibility to interference, and associative 
learning were all impaired following electrode implantation (Saint-Cyr et al., 2000). 
Participants over the age of 69 also performed significantly worse post-operatively as 
compared to some of the younger participants who nevertheless were also vulnerable to 
cognitive decline. This is in line with previous research which states that patients with 
cognitive impairment before surgery or older than 69 are at risk of worsening after 
surgery (Dowsey-Limousin & Pollak, 2001). 
 Gironell et al. (2003) also examined the consequences on STN DBS on cognitive 
function in a controlled comparison design. Sixteen patients were evaluated 1 month 
before surgery and again at 6 months post-surgery. The same assessments were 
performed in a control group of eight matched PD patients recruited from surgery 
candidates who refused the operation. The neuropsychological battery consisted of tests 
measuring memory, attention, arithmetic, problem solving and language, as well as 
visuospatial ability and executive function. The main finding was that bilateral STN DBS 
did not result in global neuropsychological impairment relative to pre-surgical baseline. 
However, a slight effect was found for a selective decrease in verbal fluency (Gironell et 
al., 2003).  
Significantly decreased verbal fluency is one of the most consistent findings 
across studies (Gironell et al., 2003). Verbal fluency is a composite task, with multiple 
cognitive subcomponents (e.g. conceiving and application of a retrieval strategy, shifting 
between subcategories, vocabulary access, semantic processing), which may be classified 
as either executive or semantic in nature (Gaspari et al., 2006). Qualitative analysis of 
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verbal fluency performance from both brain damaged patients and normal subjects has 
revealed a consistent pattern of task execution based on the generation of phonological or 
semantic subcategories, i.e. clusters (Chertkow & Bub, 1990). Cluster size and number of 
switches between clusters provide specific information about two distinct cognitive 
underpinnings of the task, i.e. the integrity of the lexical-semantic store and the ability to 
shift from an exhausted cluster to a new one (Gaspari et al., 2006). Gaspari et al. (2006) 
state that a decrease in the number of switches has consistently been shown to be 
associated with frontal or subcortical pathology. 
 Gaspari et al. (2006) hypothesized that there would be a post-surgical decrease in 
both total verbal production and in switching rate. The sample consisted of twenty-six 
patients suffering from idiopathic PD. Pre and post-surgery neurological evaluations were 
preformed using a version of the FAS test along with some other tests of executive 
function and motor ability. Results showed that comparisons between pre and post-
surgical general neuropsychological evaluations showed worsening at both raw global 
fluency scores (Gaspari et al., 2006). Additionally, number of total words and switches 
were both significantly reduced after surgery. Therefore, Gaspari et al. (2006) confirmed 
previous literature findings showing a significant, long-lasting decline in verbal fluency 
after surgery for DBS in Parkinson’s disease.  
Only a handful of studies have systematically examined the role of stimulation 
and/or medications on neuropsychological performance. Morrison et al. (2004) examined 
the neuropsychological function of 17 PD patients following bilateral STN stimulator 
implantation. However, their objective was to compare patients post-operatively both on 
and off stimulation. Eleven matched PD controls were administered the same repeatable 
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neuropsychological test battery twice. The STN DBS procedure as a whole resulted in a 
mild decline in delayed verbal recall and language functions. One patient in particular 
demonstrated significant cognitive decline on all measures following surgery. However, 
these conclusions must be viewed as preliminary because the sample size was somewhat 
small and may have limited the power of the data analyses. Additionally, the issue of 
differential practice effects as a result of the DBS surgical group having been tested one 
more time than the control group and shorter inter-test interval in the post-operative 
conditions for the surgical group, as compared to that for the control group, may have 
also influenced the results of this study (Morrison et al., 2004).  
 In addition to the study conducted by Morrison et al., Voon et al. (2006) reported 
that systematic assessment on and off STN stimulation demonstrated either no significant 
cognitive effects or improvements in processing speed, random number generation, and 
problem solving with stimulation. Conversely, performances on working memory and 
response inhibition measures under high cognitive demand conditions were shown to 
decline with STN stimulation. Also, systematic assessments on and off medications 
during STN stimulation were not associated with cognitive changes on a variety of 
neuropsychological measures, including tests sensitive to frontostriatal dysfunction 
(Voon et al., 2006). Jahanshahi et al. (2000) also observed the impact of DBS on 
executive function in Parkinson’s disease by controlling for stimulation on, off, and then 
on again. Results showed that participants showed mild improvements on tasks which 
were executive in nature.  
 Perozzo et al. (2001) also examined twenty PD patients before and after bilateral 
STN DBS surgery. Four conditions were assessed: medication on and medication off 
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during the preoperative period, and medication on/stimulation on and medication 
off/stimulation on during the post-operative period. The most relevant finding of this 
study concerns the absence of an overall cognitive decline after the surgical procedure. 
Also, there was no significant worsening in literal and category verbal fluency after 
surgery. However, it is possible that this difference in comparison to previous studies 
depends on the different angles of the electrode placement. Finally, disease severity did 
not produce any significant differences between the conditions (Perozzo et al., 2001). 
 In regards to Parkinson’s disease and postoperative neuropsychological function, 
numerous methodological issues may be to blame for contradictory and conflicting 
results. The greatest methodological issues in the current literature are the small sample 
sizes and the general absence of control groups (Voon et al., 2006). Modest sample sizes 
limit the power of a study to detect the effects of DBS on cognition and behavior and also 
limit the reliability and generalizability of findings. For example, Voon et al. (2006) 
reviewed 30 neuropsychological studies of extremely small sample sizes of STN DBS 
and found that only 2 of 30 studies had adequate power to detect large effect sizes and 
none had the power to detect small or medium effects.  
 Additionally, the absence of control groups makes it difficult to determine 
whether a change occurring after DBS might also have occurred in a non-operated 
control group, thus reflecting non-DBS factors (e.g., disease progression, medication, 
test-retest practice effects, or some other extraneous variable) (Voon et al., 2006). Fields 
and Troster (2000) state that what remains an unresolved issue is what type of control 
group should be included in DBS studies. Given the now widespread availability of DBS, 
it is increasingly difficult to recruit the most relevant control for DBS: a surgical wait list 
 29 
 
control group (Voon et al., 2006). However, even the use of a wait list control group is 
not without potential interpretative pitfalls. Since medication dosage is often greatly 
reduced after STN DBS, neurobehavioral changes, when they occur in the surgical but 
not the control group, cannot confidently be interpreted as effects of DBS. Therefore, 
existing empirical evidence appears to show biases through which conclusions can only 
confidently be drawn by using within subjects designs.  
 The last methodological issue is that of test-retest effects. For example, scores 
may improve simply due to experience with the test rather than improvement of the 
function being evaluated. Strategies to minimize practice effects include employing 
multiple versions of the test that differ in specific content but not in difficulty, 
maximizing the test-retest interval, or utilizing statistical techniques. Notably, a 
familiarity or “test wise” effect may occur even when alternate forms are used (Voon et 
al., 2006). However, it is important to note that if practice effects do occur in PD patients, 
then a lack of gain may represent a decline. Furthermore, if practice effects occur, then 
small declines in scores may actually represent a sizable deterioration in function, and a 
score gain would have to exceed the practice effect before it is considered an 
improvement (Voon et al., 2006). Therefore, researchers should always address and be 
aware of the methodological issues when comparing pre and post-operative 
 neuropsychological function of patients with idiopathic Parkinson’s disease.  
Stimulation Parameters and Cognitive Function 
 Very few studies have examined the relationship between stimulation parameters 
and cognition, behavior, or subjective psychotropic effects. No studies have 
systematically varied stimulation parameters and assessed cognition in a within-subject 
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design (Voon et al., 2006). However, one problem that has been noted is a developed 
tolerance to certain stimulation parameters (Benabid et al., 1998). If tolerance to 
stimulation does occur, then higher stimulation intensities may be necessary to sustain 
adequate motor benefit. The degree to which stimulation intensities can be increased 
before cognitive side effects become clinically remarkable is unknown (Fields & Troster, 
2000). 
 A recent study conducted by Tornqvist, Schalen, and Rehncrona (2005) evaluated 
the effects of different electrical parameter settings on the intelligibility of speech in 
patients with Parkinson’s disease bilaterally treated with deep brain stimulation in the 
subthalamic nucleus. Amplitude and frequency were varied as ten PD patients read a 
standard running text and five nonsense sentences per setting. Results showed that with 
the patients’ normally used settings, there were no significant group differences between 
DBS off and on, but in four patients the intelligibility of speech deteriorated with DBS 
on. However, the higher frequencies or increased amplitude caused significant 
impairments of intelligibility. Therefore, careful individual programming of the DBS 
treatment is needed to achieve a clinically optimal balance between satisfactory motor 
function and intelligibility of speech (Tornqvist et al., 2005). 
Research Questions 
 It has been established that deep brain stimulation is now widely accepted as one 
of the favored treatments with patients whom have Parkinson's disease. While the 
relationship between DBS of the STN and post-surgical neuropsychological function in 
PD patients has been established with varying results, no study to date has investigated 
the relationship between DBS settings and neuropsychological function. This study 
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evaluated the extent to which DBS settings (i.e., amplitude, frequency, and pulse width) 
are associated with post-operative performances on the RBANS. This study was designed 
to answer these research questions: 
Question 1: What are the neuropsychological effects on Parkinson’s patients from 
baseline to post DBS surgery? 
Question 2: What is the nature of the relationship between amplitude, frequency, 
and pulse width and consequent performance on measures of memory, language, 
attention, and visuospatial/constructional ability?  
Questions 3: Can the stimulation parameters predict subsequent performance on 
neuropsychological tests? 
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CHAPTER III 
METHOD 
Research Subjects 
 20 PD participants, both male (N=10) and female (N= 10), underwent bilateral 
deep brain stimulation of the STN. The mean age of the DBS Parkinson’s sample was 
66.7 (SD= 9.38) with 13.4 years of education. Disease duration was 9.4 years (SD= 5.1). 
All participants were recruited through the Oklahoma University Medical Center 
Departments of Neurology and Neurosurgery. All subjects were diagnosed with PD by a 
board certified neurologist who also stated the participants’ disease severity using the 
Hoehn and Yahr scale. All Hoehn and Yahr ratings were performed while the participants 
were taking medication. Medications used to treat Parkinson’s disease were converted to 
dopamine equivalents. All DBS participants had significant PD related motor symptoms 
which interfered with activities of daily living and were no longer adequately relieved by 
medications. No participants had a previous history of another suspected or known 
central nervous system disease or injury besides PD or a history of major psychiatric 
disturbance or dementia.  
Procedure 
 The records of 20 idiopathic PD patients admitted to the Oklahoma University 
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Medical Center Departments of Neurology and Neurosurgery were evaluated. DBS 
participants were evaluated approximately 1 month before surgery and 5-6 months after 
surgery. Demographic data were collected for each subject and included age, education, 
gender, and test-retest interval. All participants completed extensive neuropsychological 
evaluations that included: the Hoehn and Yahr rating scale, the Unified Parkinson 
Disease Rating Scale (UPDRS), the Mini Mental Status Exam (MMSE), the State Trait 
Anxiety Inventory (STAI), California Card Sorting Task, and the Repeatable Battery for 
the Assessment of Neuropsychological Status (RBANS). However, for the purposes of 
this study, only the RBANS was used in the primary analysis.  
Surgical Procedures 
 Cranial MRI and stereotactic procedures were used to target the STN nucleus on 
each side of the brain. A four pole Medtronic DBS electrode was positioned at the target 
site where stimulation resulted in good motor symptom control. Next, the generator was 
placed in the chest and connected to the electrodes. Stimulation parameters were 
programmed by a trained health care professional after the patient recovered from 
surgery.  
Measures 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) 
 
The RBANS (Randolph, 1998) is a brief, individually administered test measuring 
attention, language, visuospatial/constructional abilities, and immediate and delayed 
memory. The test is comprised of 12 subtests, which yield five index scores (Attention, 
Language, Visuospatial/Constructional, Immediate Memory, and Delayed Memory) and 
a Total Scale score. Normative scores were developed using a stratified, nationally 
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representative sample of 540 healthy, primarily Caucasian adults aged 20-89 years. The 
normative data of Randolph (1998) were employed for the current study. All subtests 
were administered and scored as defined in the manual. In the present study, Form A of 
the RBANS was utilized at each assessment. 
Hoehn and Yahr Scale 
The Hoehn and Yahr scale (Hoehn, & Yahr, 1967) is a commonly used system for 
describing how the symptoms of Parkinson’s disease progress. Because of the variability 
with which the syndrome evolves, it is essential to consider the extent of disability at the 
time of treatment and the rate of progression before and after treatment. Each case is 
rated on an arbitrary scale (I-V) based on the level of clinical disability. Stage I consists 
of unilateral involvement only, usually with minimal or no functional impairment. Stage 
II consists of bilateral or midline involvement, without impairment of balance. Stage III 
is the first sign of impaired reflexes. This is evident by unsteadiness as the patient turns 
or is demonstrated when he or she is pushed from standing equilibrium with the feet 
together and eyes closed. Overall, their disability is mild to moderate. Stage IV means the 
patient has fully developed the severely disabling disease; the patient is still able to walk 
and stand unassisted but is markedly incapacitated. In the final stage, Stage V, the patient 
is confined to a bed or wheelchair unless aided. This method of staging is practical and 
allows for reproducible assessments by independent examiners of the general functional 
level of the patient (Hoehn and Yahr, 1967).  
State-Trait Anxiety Inventory (STAI) 
The State-Trait Anxiety Inventory (Spielberger, 1983) has been used extensively 
 35 
 
both in clinical practice and in research. It comprises separate self-report scales for 
measuring state and trait anxiety. The S-Anxiety scale (STAI Form Y-1) consists of 
twenty statements that evaluate how respondents feel “right now, at this moment”. The T-
Anxiety scale (STAI Form Y-2) consists of twenty statements that assess how people 
generally feel. The essential qualities evaluated by the STAI-S Anxiety scale are feelings 
of apprehension, tension, nervousness, and worry. In addition to assessing how people 
feel right now, the scale is also used to see how people anticipate they will feel in future 
situations. The STAI-T Anxiety scale has been widely used in assessing clinical anxiety 
in medical, surgical, psychosomatic, and psychiatric patients (Spielberger, 1983). It is 
also used for screening high school, college students, and military recruits for anxiety 
problems, and for evaluating the immediate and long-term outcome of psychotherapy and 
counseling. With both scales, higher scores yield increased levels of anxiety and worry.  
Unified Parkinson Disease Rating Scale (UPDRS) 
 The Unified Parkinson Disease Rating Scale is a rating tool to follow the 
longitudinal course of Parkinson’s disease. It is made up of the following scales: 
Mentation, behavior, and mood scale, activities of daily living scale, and motor sections. 
All ratings are evaluated by interview by a trained healthcare professional. Some sections 
require multiple grades assigned to each extremity. A total of 199 points are possible, 
with 199 representing total disability and 0 being equal to no disability. Clinicians and 
researchers alike use the UPDRS and motor section in particular to follow the 
progression of PD. The motor section consists of 14 questions based on the areas of 
posture, speech, gait, tremor, rigidity, and bradykinesia, among others. These areas are 
rated on a 4-point likert scale, with 0 being normal and 4 meaning that the patient can 
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barely perform the task. For the purposes of this paper, only the motor section of this 
scale was used.  
Analyses  
 The DBS group’s pre and post-surgical z scores were compared for all RBANS 
index and individual subtests using paired samples t-tests. No significant differences 
between pre and post surgery were found. Additionally, the group’s pre and post-surgical 
motor function was compared using the motor section of the UPDRS. There was a 
significant difference between pre and post-surgery, thereby validating improvement in 
motor function following DBS surgery. In the primary analysis, a Pearson product 
moment correlation was performed to determine the relationship between RBANS index 
and subtest scores with stimulation parameters (amplitude, frequency, and pulse width). 
Additionally, a partial correlation was conducted in order to examine the relationship 
between the RBANS and stimulation parameters while controlling for motor impairment, 
dopamine use, and level of anxiety. In order to determine the best predictors for the 
RBANS index and subtest scores, stepwise and hierarchal multiple regression analyses 
were performed.  
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CHAPTER IV 
RESULTS 
Demographics 
 A total of 20 participants were administered the RBANS along with other 
neuropsychological measures. The participant’s average age was 66.65 and the average 
education level was 13.35. Disease duration in years was an average of 9.40 (see Table I). 
Table I. 
Descriptive statistics for the sample population (N=20) 
  Mean  Std. 
Deviation 
 
Range 
Age 66.65 9.38 48-79 
Education 13.35 2.28 9-18 
Disease Duration 
(years) 
9.40 5.11 5-18 
 
 
 
 
 
 
 
 
 
Research Questions 
Question 1: What are the neuropsychological effects on Parkinson’s patients from 
baseline to 6 months post DBS surgery? 
 A Paired samples T-Test was conducted to determine whether there was a 
significant difference between the pre and post surgical neuropsychological function of 
Parkinson’s patients. The goal was to determine whether this group differed with regard 
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to the 5 index scores and 12 individual subtest scores on the RBANS. The means, 
standard deviations, and ranges of the DBS group and their scores from baseline to 6 
months post surgery can be found in Tables 1 and 2 in the Appendix. Z scores indicate 
that taken overall, neuropsychological function improved, but not significantly, from 
baseline to post surgery. Table II displays the mean differences in scores between 
baseline and follow-up using the RBANS index scores. Although no significant 
differences were found, the visuospatial/constructional index approached significance at 
.06 (p< .05). A Paired samples T-Test was also conducted to confirm the common 
findings of increases in motor function post DBS surgery. Results using the UPDRS 
motor section were significant and can be found in Table II. 
Table II. 
Differences in z-scores between baseline and follow-up on the RBANS and UPDRS (N= 20) 
 Paired Differences    
 Mean SD Std. Error 
Mean 
t df Sig. 
(2-tailed) 
 
Total Score 
 
-.19 
 
.93 
 
.21 
 
-.90 
 
19 
 
.38 
 
Attention 
 
-.06 
 
1.13 
 
.25 
 
-.23 
 
19 
 
.81 
 
Language 
 
-.10 
 
1.08 
 
.24 
 
-.42 
 
19 
 
.67 
 
Visuospatial/Constructional 
 
-.46 
 
1.01 
 
.23 
 
-2.03 
 
19 
 
.06 
 
Immediate Memory 
 
-.44 
 
1.54 
 
.34 
 
-1.29 
 
19 
 
.21 
 
Delayed Memory 
 
-.46 
 
1.56 
 
.35 
 
-.92 
 
19 
 
.37 
 
UPDRS- Motor section 
 
8.85 
 
8.34 
 
2.31 
 
3.83 
 
19 
 
.002* 
Significant at p< .05. 
 Question 2: What is the nature of the relationship between amplitude, frequency, 
and pulse width and consequent performance on measures of memory, language, 
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attention, and visuospatial/constructional ability?  
Pearson product moment correlations were computed to investigate the 
relationship between stimulation parameters and performance on measures of attention, 
language, memory, and visuospatial/constructional ability (see Table III). Descriptive 
statistics for the stimulation parameters can be found in Table 3 in the Appendix. Results 
indicated that amplitude was positively related to the visuospatial/constructional index (r 
= .545, p< .05) and pulse width was positively related to the immediate memory index (r 
= .448, p< .05). Therefore, as amplitude and pulse width increase, there is an increase in 
performance on memory and visuospatial/constructional tasks. Results also indicated that 
amplitude and the line orientation subtest were correlated (r = .449, p< .05) along with 
pulse width and the delayed figure recall (r = .455, p< .05). Although other relationships 
were found to be moderately correlated, they were not found to be significant. 
Table III. 
Correlation Coefficients between Follow- up RBANS Index and Subtest Scores and Stimulation 
Parameters 
RBANS Index and Subtest Scores Amplitude Frequency Pulse Width 
Attention Index .003 -.104 .112 
     Digit Span -.242 -.166 .010 
     Coding .257 -.091 .107 
Language Index -.231 .127 .078 
     Picture Naming .352 .174 .025 
     Semantic Fluency -.190 .057 .109 
Immediate Memory Index .386 .213 .448* 
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RBANS Index and Subtest Scores Amplitude Frequency Pulse Width 
     List Learning .182 .225 .337 
     Story Memory .426 .202 .363 
Delayed Memory Index .320 .202 .347 
     Delayed List Recall .271 .125 .368 
     Delayed List Recog. .150 .089 .242 
     Delayed Story Recall .120 .261 .096 
     Delayed Figure Recall .400 .278 .455* 
Visuospatial/Construction Index .545* .283 .322 
     Figure Copy .428 .345 .433 
     Line Orientation .449* .172 .048 
*Correlation is significant (p< .05) 
Incidental Findings  
 In order to further validate the relationship between the stimulation parameters 
and neuropsychological function post-DBS surgery, a partial correlation was performed 
in order to assess whether disease severity, motor symptoms, and symptoms of anxiety 
were contributing factors to the changes observed at 6 months post surgery. In order to 
assess the role of disease severity and the motor components of Parkinson’s disease, the 
Hoehn and Yahr scale and dopamine medication daily dosage were used as co-variates 
for the previous analysis For the anxiety component, the State-Trait Anxiety Inventory 
was also co-varied. Descriptive statistics for the dopamine medication daily dosage and 
State-Trait Anxiety Inventory can be found in Table IV.  
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Table IV. 
Descriptive Statistics for Dopamine Dosage and Anxiety Symptoms 
 Mean 
 
Std. Deviation Range 
Baseline dopamine 
equivalent med. 
dose 
 
716.27 
 
334.85 
 
25.46-1368.00 
  
690.52 
 
362.47 
 
Follow up dopamine 
equivalent med. 
dose 
0.00-1368.00 
  
1.16 
 
1.45 
 
Baseline STAI-S 
anxiety score 
-1.41-3.78 
  
1.17 
 
1.26 
 
Follow up STAI-S 
anxiety score 
-1.13-3.90 
  
1.33 
 
1.53 
 
Baseline STAI-T 
anxiety score 
-1.52-3.63 
  
1.04 
 
1.59 
 
 
Follow up STAI-T 
anxiety score 
-1.39-4.91 
In using the Hoehn and Yahr Scale as a covariate for the above analysis, no 
significant relationships were found because not all participants were given this measure 
at follow-up. Therefore, disease severity was excluded from all further analyses. 
However, when controlling for dopamine daily dosage, significant correlations were 
found between the stimulation parameters and RBANS scores (see Table V). Results 
indicated that pulse width was positively related to the immediate memory index (r = 
.483, p< .05) and amplitude was correlated with the visuospatial/constructional index (r = 
.537, p< .05).  When looking at individual subtest scores of the RBANS while controlling 
for dopamine daily dosage, similar results were found.  There was a positive correlation 
between pulse width and both the figure copy subtest (r = .492, p< .05) and the delayed 
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figure recall (r = .518, p< .05). These relationships were similar to the ones found above, 
which indicates that dopamine does not play a role post surgically in enhancing the 
neuropsychological functioning of Parkinson’s patients. Moderate correlations were 
found between amplitude and story recall, figure copy, and line orientation, as well as 
with pulse width and list delayed recall.  
Table V. 
Correlation Coefficients between RBANS Scores and Stimulation Parameters when 
Controlling for Dopamine Daily Dosage 
RBANS Index and Subtest Scores Amplitude Frequency Pulse Width  
Attention Index -.032 -.070 .187 
     Digit Span -.271 -.145 .053 
     Coding .235 -.047 .207 
Language Index -.209 .094 .017 
     Picture Naming .339 .205 .069 
     Semantic Fluency -.173 .035 .074 
Immediate Memory Index .379 .230 .483* 
     List Learning .166 .251 .385 
     Story Memory .419 .218 .395 
Delayed Memory Index .313 .215 .374 
     Delayed List Recall  .263 .140 .400 
     Delayed List Recognition .165 .076 .225 
     Delayed Story Recall .098 .300 .150 
     Delayed Figure Recall .388 .311 .518* 
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RBANS Index and Subtest Scores Amplitude Frequency Pulse Width  
Visuospatial/Constructional Index .537* .325 .390 
     Figure Copy .417 .380 .492* 
     Line Orientation  .439 .215 .110 
*Correlation is significant (p< .05) 
When anxiety was co-varied, significant correlations were also found (see Table 
VI). Results showed that pulse width was significantly related to both the immediate 
memory index (r = .552, p<.05) and the delayed memory index (r = .567, p<.05). Results 
also showed a significant relationship between amplitude and the immediate memory 
index (r = .489, p< .05) and the visuospatial/construction index (r = .567, p< .05). When 
looking at the individual subtests, significant correlations were found between pulse 
width and story recall (r = .549, p< .05), figure copy (r = .514, p< .05), list delayed recall 
(r = .494, p< .05), and delayed figure recall (r = .553, p< .05). Correlations were also 
found between amplitude and story recall (r = .489, p< .05). Moderate correlations were 
found between amplitude and pulse width with other measures of the RBANS, but lacked 
significance. Therefore, it appears as though amplitude and pulse width also have a direct 
relationship with memory and visuospatial/constructional ability when medication dosage 
and anxiety are controlled.  
Table VI. 
Correlation Coefficients between RBANS Scores and Stimulation Parameters when 
Controlling for Anxiety 
RBANS Index and Subtest Scores  Amplitude Frequency Pulse Width 
Attention Index .003 .201 .268 
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RBANS Index and Subtest Scores  Amplitude Frequency Pulse Width 
     Digit Span -.161 -.327 .072 
     Coding .164 -.088 .333 
Language Index -.192 .100 .056 
     Picture Naming .380 .151 .230 
     Semantic Fluency -.171 .046 .090 
Immediate Memory Index .489* .148 .552* 
     List Learning .289 .156 .393 
     Story Memory .489* .159 .549* 
Delayed Memory Index .399 .140 .470* 
     Delayed List Recall .316 .075 .494* 
     Delayed List Recognition .224 .038 .268 
     Delayed Story Recall .198 .181 .251 
     Delayed Figure Recall .382 .312 .553* 
Visuospatial/Constructional Index .567* .294 .463 
     Figure Copy .414 .386 .514* 
     Line Orientation  .437 .192 .179 
*Correlation is significant (p< .05) 
Question 3: Can the stimulation parameters predict subsequent performance on 
neuropsychological tests? 
A stepwise multiple regression analysis was performed in order to assess whether 
amplitude, frequency, pulse width, the STAI, and dopamine daily dosage best predicted 
performance on tasks on attention, language, memory, and visuospatial/constructional 
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ability (see Table 7). The State-Trait Anxiety Inventory predicted performance on the 
picture naming subtest (R2= .24) and together with pulse width on the coding subtest of 
the RBANS (R2= .38). The RBANS immediate memory index score was best predicted 
by pulse width, which accounted for 20% of the variance (R2= .20), along with the State-
Trait Anxiety questionnaire, which predicted 16% of the total variance (R2= .16). Story 
memory was significantly predicted by pulse width and the State-Trait Anxiety 
Inventory. The delayed list recall was predicted by both pulse width (R2= .14) and the 
STAI (R2= .15), while the RBANS delayed story recall score was best predicted by the 
State-Trait Anxiety Inventory alone (R2= .20). The delayed figure recall subtest was best 
predicted by pulse width (R2= .21) along with the State-Trait Anxiety Inventory (R2= 
.13). Finally, amplitude and the STAI were found to significantly predict RBANS 
visuospatial/constructional index scores, accounting for 39% of the total variance.  
Table VII. 
Stepwise Regression Analysis of Stimulation Parameters, the STAI, and Dopamine 
Equivalents with Scores on the RBANS 
 Predictor Standardized Beta Weights   
 
 
 
Amplitude 
 
Freq.
 
Pulse 
Width 
 
STAI 
 
Dop. 
Eq. 
 
F 
 
R2
RBANS Variables 
 
       
Attention Index    -.389  3.22 .15 
      
     Digit Span 
 
    
-.317 
  
2.01 
 
.10 
     Coding   .298 -.634  5.15* .38 
 
Language Index 
   
 
  
-.307 
 
1.87 
 
.09 
 
     Picture Naming    -.493  5.80* .24 
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Predictor Standardized Beta Weights 
 
 
 
Amplitude 
 
Freq.
 
Pulse 
Width 
 
STAI 
 
Dop. 
Eq. 
 
F 
 
R2
RBANS Variables 
 
       
 
     Semantic Fluency  
    
 
   
 
Imm. Memory Index 
 
 
  
.559 
 
-.408 
  
4.68* 
 
.36 
 
     List Learning 
   
.419 
 
-.303 
  
2.10 
 
.20 
      
     Story Memory 
 
.278 
  
.338 
 
-.488 
  
3.90* 
 
.42 
 
Delayed Memory Index 
 
   
.463 
 
-.426 
  
3.45 
 
.29 
     Del. List Recall 
 
  .480 -.410  3.49* .29 
     Del. List Recog.         
 
     Del. Story Recall 
 
    
-.443 
  
4.39* 
 
.20 
     Del. Figure Recall   .568 -.376  4.30* .34 
 
VS/Construction Index 
 
.571 
   
-.299 
  
5.33* 
 
.39 
 
     Figure Copy 
 
 
  
.533 
 
-.332 
  
3.43 
 
.29 
 
     Line Orientation  
 
.476 
  
 
 
-.296 
  
3.45 
 
.29 
*Significant at p< .05 
 A hierarchal multiple regression was conducted in order to ensure that other 
variables were not confounding the relationship between dopamine daily dosage and the 
STAI with RBANS index and subtest scores. However, no significant relationships were 
found for dopamine, thus supporting the previous analyses in that dopamine daily dosage 
is not a factor in measuring the neuropsychological function of Parkinson’s patients 6 
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months post DBS surgery. The only significant relationships found using the STAI were 
picture naming and delayed story recall, which was also found in the above analyses.  
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CHAPTER V 
DISCUSSION 
 The goal of this study was to answer the following research questions: what are 
the neuropsychological effects on Parkinson’s patients from baseline to post DBS 
surgery; what is the nature of the relationship between amplitude, frequency, and pulse 
width and consequent performance on measures of memory, language, attention, and 
visuospatial/constructional ability; and can the stimulation parameters predict subsequent 
performance on neuropsychological tests. Overall, neuropsychological performance 
improved slightly from pre to post DBS implantation, though results were not significant. 
Memory, both immediate and delayed, and visuospatial/constructional ability were the 
two areas where patients showed the most improvement, as compared to language and 
attention in which patients showed a mild to moderate decline or no change at all. 
However, it is important to note that when comparing the indices from pre to 6 months 
post surgery, no significant differences were found.  
 These results indicate that DBS surgery tends to be a relatively benign procedure 
from a neuropsychological standpoint. That is, this particular sample showed some 
improvements in the areas of memory and visuospatial/constructional ability, while other 
areas, such as language and attention, showed mild to moderate declines. Thus, the 
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results appear to be mixed. That is, some of the data support the literature on the pre and 
post surgical neuropsychological function of PD patients. Data comparing the current 
study with other research in the field can be found in Table 4 in the appendix.  
Currently, the data suggests that attention, both divided and sustained, tends to be 
relatively impaired in PD patients. In the sample used in this study, PD patients showed a 
decline in digit span, which is an attention task that is also used to assess concentration, 
sequencing, and auditory short-term memory. Furthermore, PD patients showed a marked 
decline in a coding task, which measures not only visual motor coordination and mental 
speed, but also requires executive control of attention and sustained effort in order to 
complete the task. These results are consistent with current research (Saint-Cyr et al.; 
Gironell et al.). Therefore, it appears as though DBS implantation has a relatively small 
effect on improving the attention of PD patients. 
Language is another area of impairment among PD patients that is marked by a 
progressive decrease in total word output. This sample of PD patients showed a rather 
large decline in verbal fluency post surgery which is consistent with current findings 
(Morrison et al.; Saint-Cyr et al.; Gironell et al.; Gaspari et al.; Perozzo et al.). The 
explanation for language decline consistently points to retrieval failures. That is, PD 
patients, among others with subcortical and cortical neurodegenerative diseases, tend to 
have impaired lexical retrieval which is largely independent of memory stores. Taken 
together, these data suggest that deep brain stimulator surgery may actually be a 
confounding variable to the reported decrease in verbal fluency following surgery.  
Although memory and visuospatial/constructional ability are typically considered 
to be areas showing a pronounced cognitive decline in PD patients (Morrison et al.; 
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Saint-Cyr et al.; Gironell et al.; Voon et al.), this sample found opposite results. On 
visuospatial/constructional tasks of an executive nature, PD patients showed a rather 
marked improvement in the drawing a complex figure and a problem solving task of 
frontal lobe functioning. Additionally, patients also showed improvements in both 
immediate and delayed recall. Recent studies have shown that PD patients tend to show a 
decline in recall and an improvement in recognition. However, with this sample, the 
opposite was true. That is, when patients were asked to recall a list of words after a short 
delay, they slightly improved. Conversely, when patients were asked to recognize words 
out of a longer word list, their performance declined.  
When examining the relationship between the stimulation parameters and 
neuropsychological function, significant correlations were found between pulse width 
and the immediate memory index score and figure recall. Significant correlations were 
also found between amplitude and the visuospatial/constructional index score and line 
orientation. Due to the influence of anxiety and dopamine medication dosage on PD 
patients, partial correlations were conducted which showed that relationships were still 
significant between amplitude and pulse width with measures of memory, both 
immediate and delayed, and visuospatial/constructional ability. This implies that 
increases in the stimulation parameters of amplitude and pulse width may be the cause of 
enhanced neuropsychological performance post DBS surgery.  
To assess whether or not the stimulation parameters, along with the State-Trait 
Anxiety Inventory and dopamine daily dosage, would be able to predict subsequent 
neuropsychological performance and account for the variance in the test scores, a linear 
stepwise multiple regression was conducted. Results showed that the STAI, pulse width, 
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and amplitude were able to predict performance on measures of attention, language, 
immediate memory, delayed memory, and visuospatial/constructional ability. It is 
important to note that amplitude, pulse width, and the STAI almost reached 
significance with other measures of the RBANS; specifically with the attention index 
score, delayed memory index score, figure copy subtest score, and line orientation subtest 
score. A probable explanation for why they did not reach significance may be due to the 
small sample size. As with other studies, the current study is underpowered as it only 
consisted of twenty participants. Underpowered studies increase the likelihood of 
producing a false negative, which may pose an explanation as to why no significant 
differences were found amongst other subtests or indices of the RBANS. Therefore, 
because the effect size was so small, the probability of finding statistically significant 
differences was also small.  
Clinical Implications  
 In putting these results in a clinical context, it appears that the DBS settings used 
in this study had a mild effect on neuropsychological function. It is important to note that 
patients reported increased motor function post-surgery which lead to an increased 
quality of life. Taken together, the non-significant findings should not necessary be 
viewed as negative because there were no substantial decreases in function. On the other 
hand, the significant findings pose considerable clinical benefits. The fact that aspects of 
memory, both immediate and delayed, and visuospatial/constructional ability increased 
slightly and were correlated with the stimulation parameters of amplitude and pulse width 
is a new finding in the literature. Therefore, the stimulator settings used in the current 
study appear to have both neuropsychological and motor benefits. Overall, the study 
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confirms that DBS surgery does not carry large risks for dramatic decreases in 
neuropsychological functioning post surgery.  
 An additional finding in this study that carries large clinical impacts was the 
presence of anxiety. High levels of anxiety were reported from participants both before 
and after surgery. Although levels of anxiety decreased from pre to post surgery, anxiety 
was still a significant factor in predicting neuropsychological outcome. Therefore, it 
would be fair to conclude that decreases in anxiety post-surgery may have a significant 
effect on attention, language, memory, and visuospatial/constructional ability in PD 
patients. In the sense of applying this information clinically, perhaps health care 
professionals should turn more to psychological treatments of anxiety, whether it is talk 
therapy or medical therapy, following DBS surgery in order to improve the cognitive 
function in PD patients. While it has been proposed that depression and anxiety are 
highly correlated, future research may focus on aspects of mood in treating PD patients 
post-surgery.  
Due to the amount of intraindividual variability found within the previous 
literature and the current study, it is important to note that some patients may exhibit 
more pronounced impairments. Additionally, different stimulation settings may affect 
patients differently. It has been noted that increases in amplitude and frequency may have 
a more positive effect on the neuropsychological function of the patient, but may cause 
an increase in the motor symptoms of the disease. Therefore, there appears to be a trade-
off to what patients would more likely value. That is, would they rather have increased 
motor function or increased neuropsychological function. As was demonstrated by this 
study, frequency, or the rate of stimulation, had no effect on the neuropsychological 
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function of PD patients. Due to that variability, these results should be taken with caution 
and should be used only as a guideline on which to base future studies.  
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CHAPTER VI 
CONCLUSION 
Overall, it appears that the DBS settings of amplitude and pulse width are 
positively correlated with aspects of memory and visuospatial/constructional ability in 
PD patients as was measured using the RBANS. Additionally, pulse width, amplitude, 
and the STAI were found to be significant predictors accounting for a rather large amount 
of the variance for the memory and visuospatial/constructional tasks. While this study has 
some limitations, a follow-up study might investigate the performance of a larger group 
on a similar, if not the same task, to assess neuropsychological function. Also, one may 
want to use similar but equivalent tasks in order to eliminate test-retest effects. Additional 
studies might compare groups of PD patients whom have all undergone DBS surgery to 
evaluate the differences in the stimulator settings and compare those to scores on tasks 
assessing memory, attention, language, and visuospatial/constructional ability. From 
there, one may be able to better differentiate which settings lead to the most improvement 
in neuropsychological function post-surgery.   
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Table 1 
Descriptive Statistics for RBANS Index Z-Scores Pre to Post Surgery (N=20) 
 Pre-Surgery  Post-Surgery 
RBANS Index 
Scores 
Mean Std. 
Deviation 
 
Range Mean  Std. 
Deviation 
Range 
Total Score -1.23 .94 (-2.80)-(.20) -1.05 1.14 (-3.00)-(1.27) 
Attention  -1.38 1.23 (-5.20)-(.20) -1.32 1.12 (-3.13)-(.40) 
Language -.76 1.25 (-5.27)-(.53) -.66 .41 (-1.33)-(.33) 
Visuospatial/ 
Constructional 
 
-1.02 1.57 (-5.33)-(1.40) -.56 1.28 (-3.13)-(2.07) 
Immediate 
Memory 
 
-1.21 1.55 (-5.07)-(.93) -.77 1.19 (-2.87)-(1.13) 
Delayed 
Memory 
-1.12 1.46 (-5.27)-(.67) -.80 1.29 
 
(-3.20)-(.87) 
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Table 2 
 
Descriptive Statistics for RBANS Subtest Z-Scores Pre to Post Surgery (N=20) 
 
 Pre Surgery 
 
Post Surgery 
RBANS Subtest 
scores 
 
Mean Std. 
Deviation 
Range Mean Std. 
Deviation 
Range 
List learning -1.05 1.23 (-2.67)-(.88) -.78 1.18 (-3.11)-(1.28) 
Story Memory -1.25 1.39 (-4.28)-(1.00) -.77 1.29 (-3.44)-(1.28) 
Figure Copy -.71 1.65 (-3.78)-(1.29) -.45 1.43 (-3.78)-(1.29) 
Line Orientation -1.02 1.47 (-3.36)-(.93) -.71 1.63 (-4.00)-(1.29) 
Picture Naming .15 .83 (-2.29)-(.67) -.34 .86 (-1.40)-(.90) 
Semantic 
Fluency 
 
-.77 .95 (-2.61)-(.81) -1.11 .75 (-2.39)-(.80) 
Digit Span -.23 .88 (-2.00)-(1.09) -.39 .87 (-2.16)-(.86) 
Coding -1.91 1.02 (-3.68)-(-.03) -2.01 1.45 (-4.70)-(.08) 
List Delayed 
Recall 
 
-.85 1.38 (-3.32)-(1.24) -.69 1.30 (-2.73)-(2.04) 
List Recognition -.62 1.58 (-6)-(1) -.92 1.61 (-4.50)-(.67) 
Story Delayed 
Recall 
 
-1.40 1.60 (-4.94)-(.91) -.64 1.25 (-2.73)-(1.17) 
Delayed figure 
recall 
-1.19 .78 (-2.74)-(.45) -.60 1.35 (-3.40)-(1.31) 
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Table 3 
Descriptive Statistics for the Stimulation Parameters  
 Mean Std. Deviation Range 
Frequency (Hz) 149.25 19.75 130.00-185.00 
Amplitude (mV) 1.72 .63 0.80-3.70 
Pulse Width (µs) 82.50 25.52 60.00-150.00 
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Table 4 
 
Comparison of Studies of Neuropsychological Function Following DBS Implantation 
 
Cognitive Function Increase, Decrease, or No Change 
  
+ 
 
- 
 
0 
 
 
Memory 
  
1 
2 
5 
 
3 
7* 
 
 
 
Language 
  
1 
2 
3 
4 
6 
7* 
 
 
Attention 
  
2 
7* 
 
3 
 
 
Visuospatial/Construction 
   
3 
7* 
1= Morrison et al. 
2= Saint-Cyr et al. 
3= Gironell et al. 
4= Gaspari et al. 
5= Voon et al. 
6= Perozzo et al. 
*7= Current Study 
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